$RGTI REPORTS Q2 AFTER TODAY'S CLOSE
→ Consensus is $5.09M in revenue and -$0.05 EPS expected, versus Q1 revenue of $4.4M and non-GAAP EPS of -$0.04
→ Q1 operating loss was $26.0M; cash, cash equivalents and investments totaled $569M
→ Cepheus-1-108Q became generally available through Rigetti QCS, Amazon Braket, Microsoft Azure Quantum and qBraid
Focus areas include Novera deliveries, system-level contracts, quantum-cloud usage, fidelity metrics and cash deployment.
$NBIS is down around 9% on the session, with profit-taking unwinding much of last week's AI rally ahead of the August 12 Q2 report.
The pullback follows a surge past $229 this week after hyperscaler earnings validated AI infrastructure demand, with the stock still trading near a 73x forward multiple.
The August 12 report is the next catalyst, with Street expectations near $576.7M in revenue versus $105.1M a year earlier.
$LLY is up around 4% today with Q2 results reported before the open showing revenue of $22.97B beating the ~$20.6B consensus and adjusted EPS of $8.38 above the $6.58 estimate.
Full-year revenue guidance was raised to $85B-$87B from $82B-$85B, with Mounjaro revenue up 91% to $9.9B and Zepbound at $4.9B.
Adjusted EPS for $LLY included $3.03 in acquired IPR&D charges. A CVS Health partnership brings Zepbound and Foundayo to the CVS app from Q4.
@VestExchange Blowing past expectations like that and immediately bumping up full year targets shows just how confident management is in the second half
$TSEM reported record Q2 revenue and profitability, with Q3 revenue guidance at a new company record of $520M ±5%.
On the session, $TSEM is down ~1%, with revenue at $460.08M versus $454.68M consensus and adjusted EPS at $0.88 versus $0.73 expected.
Gross profit reached $138M versus $111M in Q1, while SiPho annual revenue run rate reached $680M versus $180M a year ago.
$TSEM REPORTS Q2 BEFORE TOMORROW'S OPEN
→ Consensus is $454.68M in revenue and $0.73 adjusted GAAP EPS; Q1 revenue was $413.63M
→ Q1 gross profit was $111M and operating profit was $65M, up 52% and 96% YoY
→ Management's Q2 revenue guide was $455M ±5%, with $290M in Q1 customer prepayments and $1.3B of contracted silicon-photonics revenue for 2027
Focus areas include silicon-photonics demand, customer prepayments, 300mm capacity, margin progression and the record revenue guide.
Into the open, $SPCX is down around 1.8%, with the stock near the bottom of its 52-week range and more than 50% below its June peak.
Short interest is roughly $25B, while Jefferies argues the selloff reflects a broader AI-valuation reset rather than company-specific governance concerns tied to Musk's control.
Trade $SPCX volatility with a Vest Capital funded account and access up to $25k in trading capital.